Celecoxib and rofecoxib: efficacy and safety of selective inhibitors of Cox-2 compared to non-selective NSAIDs. Portuguese Journal of Family Medicine and General Practice, [S. l.], v. 20, n. 1, p. 47–64, 2004. DOI: 10.32385/rpmgf.v20i1.10008. Disponível em: https://rpmgf.pt/ojs/index.php/rpmgf/article/view/10008. Acesso em: 19 apr. 2026.